Company Filing History:

12 out of 1,624

E. R. Squibb Sons, Inc.

patents

1 out of 3,681

Bristol-myers Squibb Compnay

patents

Years Active: 1976-1994

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5364623 - Antibiotic produced by Bacillus subtilis ATCC 55422 capable of (1994-11-15),

2. 5320955 - 10'desmethoxystreptonigrin production by Streptomyces albus (1994-06-14),

3. 5165931 - Peptifluorin and neopeptifluorin (1992-11-24),

4. 5158960 - 10'-Desmethoxystreptonigrin (1992-10-27),

5. 4914245 - Culpin (1990-04-03),

6. 4842857 - Glyphomicins A and B (1989-06-27),

7. 4719109 - EM5596--an antibiotic (1988-01-12),

8. 4601904 - Antibiotics xylocandin A and xylocandin B (1986-07-22),

9. 4588588 - Antibiotic EM5487 (1986-05-13),

10. 4296101 - Antibiotic kristenin (1981-10-20),

11. 4091092 - Polymyxin F and process of producing polymyxin F (1978-05-23),

12. 4064013 - Process for preparing thiostrepton (1977-12-20),

13. 3962426 - Antibiotics LL-AC541 and racemomycin A as taeniacidal agents (1976-06-08),

Title: Edward Meyers: A Pioneer in Antibiotic Innovations

Introduction

Edward Meyers, an esteemed inventor based in East Brunswick, New Jersey, has made significant contributions to the field of microbiology and pharmaceuticals. With a robust portfolio of 13 patents, his inventions focus on developing antibiotics that target various bacterial infections, showcasing his dedication to improving healthcare.

Latest Patents

Among his latest patents is an innovative antibiotic produced by Bacillus subtilis ATCC 55422. This antibiotic boasts a nominal molecular weight of 580 and an empirical formula of C.sub.35 H.sub.48 O.sub.7, or its salts. It is particularly effective in inhibiting the growth of bacteria such as Escherichia, Klebsiella, Proteus, Serratia, Bacillus, and Staphylococcus. Additionally, he holds a patent for the production of 10'-Desmethoxystreptonigrin by cultivating a strain of Streptomyces albus, A.T.C.C. No. 55161. This compound, along with its salts, esters, and amides, has been shown to exhibit both antitumor and antibiotic activity, highlighting its promising applications in medical treatments.

Career Highlights

Edward's career has seen him working with reputable companies, including E.R. Squibb & Sons, Inc., and Bristol-Myers Squibb Company. His extensive experience in these organizations has undoubtedly contributed to his expertise in pharmaceutical innovations and antibiotic development.

Collaborations

Throughout his career, Edward has collaborated with notable professionals such as William E. Brown and Wen-Chih Liu. These partnerships have facilitated the advancement of his research and development efforts, ultimately leading to significant breakthroughs in antibiotic therapies.

Conclusion

Edward Meyers stands out as a prominent inventor in the field of antibiotics, with a commitment to combating bacterial infections through innovative solutions. His patents and collaborations illustrate a remarkable career dedicated to enhancing healthcare through science, leaving a lasting impact on the world of medicine.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.